Artificial Intelligence as a Diagnostic Tool in Non-Invasive Imaging in the Assessment of Coronary Artery Disease.
Artificial Intelligence as a Diagnostic Tool in Non-Invasive Imaging in the Assessment of Coronary Artery Disease.
复制标题
DOI:
10.3390/medsci11010020
复制
发表时间:
2023-02-24
期刊:
影响因子:
--
通讯作者:
Dastidar A
中科院分区:
文献类型:
--
作者:
Doolub G;Mamalakis M;Alabed S;Van der Geest RJ;Swift AJ;Rodrigues JCL;Garg P;Joshi NV;Dastidar A
Coronary artery disease (CAD) remains a leading cause of mortality and morbidity worldwide, and it is associated with considerable economic burden. In an ageing, multimorbid population, it has become increasingly important to develop reliable, consistent, low-risk, non-invasive means of diagnosing CAD. The evolution of multiple cardiac modalities in this field has addressed this dilemma to a large extent, not only in providing information regarding anatomical disease, as is the case with coronary computed tomography angiography (CCTA), but also in contributing critical details about functional assessment, for instance, using stress cardiac magnetic resonance (S-CMR). The field of artificial intelligence (AI) is developing at an astounding pace, especially in healthcare. In healthcare, key milestones have been achieved using AI and machine learning (ML) in various clinical settings, from smartwatches detecting arrhythmias to retinal image analysis and skin cancer prediction. In recent times, we have seen an emerging interest in developing AI-based technology in the field of cardiovascular imaging, as it is felt that ML methods have potential to overcome some limitations of current risk models by applying computer algorithms to large databases with multidimensional variables, thus enabling the inclusion of complex relationships to predict outcomes. In this paper, we review the current literature on the various applications of AI in the assessment of CAD, with a focus on multimodality imaging, followed by a discussion on future perspectives and critical challenges that this field is likely to encounter as it continues to evolve in cardiology.
登录
查看更多内容
影响因子:
4.3
作者:
Demšar J;Zupan B
通讯作者:
Zupan B
影响因子:
24
作者:
Amado, LC;Gerber, BL;Lima, JAC
通讯作者:
Lima, JAC
影响因子:
2.9
作者:
Collins GS;Dhiman P;Andaur Navarro CL;Ma J;Hooft L;Reitsma JB;Logullo P;Beam AL;Peng L;Van Calster B;van Smeden M;Riley RD;Moons KG
通讯作者:
Moons KG
影响因子:
10.6
作者:
Detsky, Jay S.;Paul, Gideon;Wright, Graham A.
通讯作者:
Wright, Graham A.
影响因子:
1.5
作者:
Arora A;Wright A;Cheng TKM;Khwaja Z;Seah M
通讯作者:
Seah M